1999
DOI: 10.1159/000007591
|View full text |Cite
|
Sign up to set email alerts
|

Endoluminal Instillation of Bisacodyl inPatients with Severe (Slow Transit Type)Constipation Is Useful to Test Residual ColonicPropulsive Activity

Abstract: Background: Chronic constipation is a frequent symptom among the general population, and a minority of cases do not respond to any therapeutic measures, except surgery. The purpose of this study was to test the residual colonic motor propulsive activity with a pharmacologic stimulus in a series of patients referred for severe constipation. Patients: Twenty-five chronically constipated patients, slow transit type, age range 16–71 years, unresponsive to conventional medical treatment and referred for functional … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
47
1
1

Year Published

2001
2001
2016
2016

Publication Types

Select...
5
4

Relationship

3
6

Authors

Journals

citations
Cited by 63 publications
(51 citation statements)
references
References 27 publications
1
47
1
1
Order By: Relevance
“…The possibility of recording colonic motor activity for prolonged periods of time (24 h or more) in the whole colon [27,28], and that of assessing visceral perception and compliance in the rectum and rectosigmoid area [29] have recently added further to our understanding of the pathophysiological basis of CDD.…”
Section: Colonic Motor and Sensory Activity In Cddmentioning
confidence: 99%
“…The possibility of recording colonic motor activity for prolonged periods of time (24 h or more) in the whole colon [27,28], and that of assessing visceral perception and compliance in the rectum and rectosigmoid area [29] have recently added further to our understanding of the pathophysiological basis of CDD.…”
Section: Colonic Motor and Sensory Activity In Cddmentioning
confidence: 99%
“…Concerning STC, some data suggest an impairment of colonic propulsive activity, represented by a reduced daily number of high-amplitude propagated contractions (HAPC), the manometric equivalent of mass movements [11, 12, 13, 14, 15]; more recently, similar data have been described in constipation-predominant IBS (C-IBS) patients [16]. However, impairment of HAPC is probably not sufficient to explain the overall derangement of colonic transport.…”
Section: Introductionmentioning
confidence: 98%
“…All in all, the available literature and those provided in the study suggest that since relamorelin might be considered as a relatively pure ''pusher,'' at least in the colon, this drug may be effective in the treatment of constipation, even though its propulsive effects seem to be relatively feeble when compared with those characteristic of other drugs [5][6][7][8]. Nevertheless, its ability to stimulate proximal gut motility [11] combined with its subcutaneous route of administration might benefit not only conventional constipated subjects, but also other subtypes of constipation such as in post-operative and neutrally compromised patients, and in patients refractory to all other medications [13].…”
mentioning
confidence: 83%
“…Therefore, since drugs can increase the frequency and amplitude of colonic contractions, especially the manometric equivalents of mass movements, termed high-amplitude propagated contractions [4], such medications could prove useful tools in constipation treatment. To date, objective documentation in humans of such stimulation is available for only a few clinically available drugs, including bisacodyl [5], macrogol [6], chenodeoxycholic acid [7], and prucalopride [8].…”
mentioning
confidence: 99%